Global Molecular Diagnostics Market to 2028

Estimated reading time: 1 minute

The global molecular diagnostics market is expected to continue to grow with a double digit CAGR of 10.89% during the forecast period, 2018-2028. Growing at a CAGR of 11.08% during the forecast period of 2018-2028, the kits and consumables product segment is anticipated to generate a value of $20.33 billion in 2028. However, the global market for software and other products is anticipated to grow at the fastest CAGR of 11.74% during the forecast period 2018-2028.

The increasing prevalence of chronic disorders and an overall increased demand for preventive medication with minimal/no side-effect are promoting the growth of the global molecular diagnostics market, providing platform for the designing and development of highly enhanced and optimum products that would direct patients to their appropriate treatment modules. These individualized care regimes are improving the quality of life of the patients and reducing economic, societal, and clinical burden, projecting a future of prosperity.

Presently, product categories within the molecular diagnostics market include kits and consumables, systems, and software and others. Till date, the healthcare industry has witnessed a number of successful products that have contributed significantly in enhancing the technological advancements in making molecular diagnostics more precise. However, the consistent evolution of the market has further necessitated the insurgence of more advanced research initiatives that look to devise the optimum assay with the confluence of multiplexing and low cost. Additionally, with systems being developed at the interface of different technologies, precision diagnostics is soon to become a widespread reality.